ProjectMJFF 026376 – An International Working Group for the Evaluation of mtDNA as a PD Biomarker
Basic data
Acronym:
MJFF 026376
Title:
An International Working Group for the Evaluation of mtDNA as a PD Biomarker
Duration:
01/10/2025 to 30/09/2027
Abstract / short description:
Establishment of an international working group to deliver an unequivocal “compare & contrast study” utilizing the various approaches in the field measuring mitochondrial DNA (mtDNA) as a biomarker for Parkinson’s disease (PD). The project goal is to bring forward the best protocol to pave the way for a large cross-cohort study and provide an entry point for precision therapeutics and improved clinical study design.
Keywords:
biomarker
Biomarker
mitochondria
Mitochondrien
Parkinson's disease
Parkinsonerkrankung
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen
University of Tübingen
Contact persons
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Hertie Institute for Clinical Brain Research (HIH)
Non-clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
New York, United States
Cooperations
Durham, North Carolina, United States
Melbourne, Victoria, Australia
Luxembourg, Luxembourg
Barcelona, Katalonien, Spain